コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ation of elevated cardiac filling pressures (pulmonary capillary wedge pressure).
2 duce systemic vascular resistance as well as pulmonary capillary wedge pressure.
3 ient, left ventricular systolic pressure and pulmonary capillary wedge pressure.
4 r flow propagation velocities for estimating pulmonary capillary wedge pressure.
5 nadequate LV diastolic filling, despite high pulmonary capillary wedge pressure.
6 heir diastolic pulmonary artery pressure and pulmonary capillary wedge pressure.
7 e infusion with simultaneous measurements of pulmonary capillary wedge pressure.
8 pulmonary fibrosis, patient age, and varying pulmonary capillary wedge pressure.
9 ween diastolic pulmonary artery pressure and pulmonary capillary wedge pressure.
10 ering mean arterial pressure, heart rate, or pulmonary capillary wedge pressure.
11 ly associated with worse symptoms and higher pulmonary capillary wedge pressure.
12 stration did not change systemic arterial or pulmonary capillary wedge pressures.
14 5.2 +/- 2.4 liters/min, p < 0.01), increased pulmonary capillary wedge pressure (17 +/- 7 vs. 14 +/-
15 -5 versus 4+/-1 mm Hg; P=0.0002), and higher pulmonary capillary wedge pressure (17+/-5 versus 9+/-3
16 essure: 105 +/- 12 mm Hg to 98 +/- 13 mm Hg; pulmonary capillary wedge pressure: 17 +/- 6 mm Hg to 21
17 essure (149 +/- 16 vs. 108 +/- 14 mm Hg) and pulmonary capillary wedge pressure (18 +/- 2 vs. 12 +/-
18 (22+/-8 versus 11+/-4 mm Hg; P=0.0001), and pulmonary capillary wedge pressure (18+/-5 versus 10+/-4
19 vaptan at 20 and 40 mg significantly reduced pulmonary capillary wedge pressure (-2.6+/-0.7, -5.4+/-0
20 essure (29+/-2 to 25+/-2 mm Hg; P<0.05), and pulmonary capillary wedge pressure (25+/-2 to 20+/-2 mm
21 enous pressure (15 vs. 13 mm Hg; p = 0.001), pulmonary capillary wedge pressure (29 vs. 24 mm Hg; p =
22 ance 24%, pulmonary vascular resistance 25%, pulmonary capillary wedge pressure 33%, and central veno
24 of therapy, net reductions in 0-hour trough pulmonary capillary wedge pressure (-4.3 mm Hg; P=0.16),
25 ues, dipyridamole resulted in an increase in pulmonary capillary wedge pressure (54 +/- 78% vs. 32 +/
26 Tolvaptan at all doses significantly reduced pulmonary capillary wedge pressure (-6.4 +/- 4.1 mm Hg,
27 rimary composite efficacy end point included pulmonary capillary wedge pressure (72 to 96 hours) and
28 ance, whereas levels of ADMA correlated with pulmonary capillary wedge pressure and both systolic and
29 e, included higher right atrial pressure and pulmonary capillary wedge pressure and lower cardiac ind
31 ventricular (LV) pressure-volume curves from pulmonary capillary wedge pressure and LV end-diastolic
33 age- and sex-related normative responses of pulmonary capillary wedge pressure and mean pulmonary ar
34 on fraction exhibit the largest increases in pulmonary capillary wedge pressure and mean pulmonary ar
35 ressure >25 mmHg in the presence of a normal pulmonary capillary wedge pressure and portal hypertensi
36 Tezosentan also dose-dependently reduced pulmonary capillary wedge pressure and pulmonary and sys
37 te analysis, cardiopulmonary exercise tests, pulmonary capillary wedge pressure and serum sodium were
38 nd-diastolic volume and Starling curves from pulmonary capillary wedge pressure and SV during lower b
39 tal effect on cardiac output, stroke volume, pulmonary capillary wedge pressure and systemic vascular
40 e with shock, pulmonary artery catheter use, pulmonary capillary wedge pressure and the incidence of
43 en shown to improve cardiac output, decrease pulmonary capillary wedge pressure, and reduce pulmonary
44 jection fraction and cardiac index, elevated pulmonary capillary wedge pressure, and renal impairment
48 lted in a significantly greater reduction in pulmonary capillary wedge pressure at 3, 4, and 8 hours
49 diography, but there was no effect of age on pulmonary capillary wedge pressure at any point througho
50 ction fraction higher than 40%, and a raised pulmonary capillary wedge pressure at rest (>15 mm Hg) o
51 After 9 weeks there were no differences in pulmonary capillary wedge pressure at rest (13+/-4 versu
52 ratio was correlated with directly measured pulmonary capillary wedge pressure at rest (r=0.63, P<0.
53 , 31 (52%) of 60 patients had a reduction in pulmonary capillary wedge pressure at rest, 34 (58%) of
54 hat this relation may be changed by elevated pulmonary capillary wedge pressure, augmenting right ven
55 nduced significant dose-related decreases in pulmonary capillary wedge pressure (average change -5.9+
56 iac performance, improving cardiac index and pulmonary capillary wedge pressure, but statistical sign
57 030 microg per kilogram per minute decreased pulmonary-capillary wedge pressure by 6.0 and 9.6 mm Hg,
58 oss the spectrum of systemic blood pressure, pulmonary capillary wedge pressure, cardiac index, and e
59 ffect on heart rate, mean arterial pressure, pulmonary capillary wedge pressure, cardiac index, or sy
60 ted statistically significant differences in pulmonary capillary wedge pressure, cardiac output, pulm
61 arterial, pulmonary artery, right atrial and pulmonary capillary wedge pressures, cardiac index, syst
62 systemic, right atrial, pulmonary artery, or pulmonary capillary wedge pressures; cardiac index; resp
63 (CHF, 48+/-12; LVAD, 30+/-5 mm Hg) and mean pulmonary capillary wedge pressure (CHF, 31+/-11; LVAD,
65 2.6-3.8 L.min(-1).m(-2)]; P<0.001) and mean pulmonary capillary wedge pressure decreased (from 15 mm
66 x increased 70.6% by 48 hours after implant, pulmonary capillary wedge pressure decreased 44%, system
67 artery mean pressure decreased 19% (P=0.03), pulmonary capillary wedge pressure decreased 46% (P=0.00
68 peratively, the cardiac index increased 43%, pulmonary capillary wedge pressure decreased 52%, system
69 rom 38.3 +/- 1.6 to 25.9 +/- 1.7 mm Hg; mean pulmonary capillary wedge pressure decreased from 25.1 +
73 d pulmonary hypertension (n=1009) and normal pulmonary capillary wedge pressure displayed a consisten
75 pressure at rest, 34 (58%) of 59 had a lower pulmonary capillary wedge pressure during exertion, and
76 2 mm Hg) or controls (9+/-2 mm Hg) displayed pulmonary capillary wedge pressure elevation (P=0.03).
78 - 5 ml/beat per min, p < 0.01) and increased pulmonary capillary wedge pressure (from 25 +/- 2 to 29
79 /Ea) greater than 10 is predictive of a mean pulmonary capillary wedge pressure greater than 15 mm Hg
80 ricular ejection fraction 21+/-1%) who had a pulmonary capillary wedge pressure >/=15 mm Hg and a car
82 ) >/=15 mm Hg (right ventricular [RV] DD) or pulmonary capillary wedge pressure >/=18 mm Hg (left ven
83 with systolic blood pressure <100 mm Hg and pulmonary capillary wedge pressure >/=24 mm Hg and depen
84 At rest, 10 patients in MI+DD (29%) had pulmonary capillary wedge pressure >15 (14+/-4 mm Hg), w
85 d units, accurately identified patients with pulmonary capillary wedge pressure >15 mm Hg (area under
86 ropic and intra-aortic balloon pump support, pulmonary capillary wedge pressure >20 mm Hg and serum c
87 York Heart Association class II-IV, elevated pulmonary capillary wedge pressure (>/=15 mm Hg at rest
89 n on echocardiography, ratio of right atrial/pulmonary capillary wedge pressure, hemoglobin) was crea
90 mm Hg increase; P = 0.022), diastolic PAP - pulmonary capillary wedge pressure (HR, 2.19; 95% CI, 1.
91 ials in congestive heart failure to decrease pulmonary capillary wedge pressure, improve cardiac outp
95 l pressure, pulmonary arterial pressure, and pulmonary capillary wedge pressure increased similarly w
97 re paradoxically increase stroke volume when pulmonary capillary wedge pressure is lowered with vasod
99 face area, cardiac index, ejection fraction, pulmonary capillary wedge pressure, left ventricular dim
100 esistance > 240 dynes x second x cm(-5), and pulmonary capillary wedge pressure < or = 15 mm Hg.
101 an pulmonary artery pressure >/=25 mm Hg and pulmonary capillary wedge pressure </=15 mm Hg at right
102 ic algorithm for discrimination between mean pulmonary capillary wedge pressure </=15 versus >15 mm H
104 venous crystalloid, furosemide, mannitol (if pulmonary capillary wedge pressure <20 mm Hg), and low-d
106 preserved cardiac index (2.4 liters/min.m2), pulmonary capillary wedge pressure of 16 +/- 9 mm Hg (me
107 monary artery pressure of 40.5+/-11.4 mm Hg, pulmonary capillary wedge pressure of 22.6+/-8.9 mm Hg,
108 ass IV, cardiac index of 1.7 L/min per m(2), pulmonary capillary wedge pressure of 25.6 mm Hg, and le
109 any level of cardiac filling volume was the pulmonary capillary wedge pressure of the seniors lower
110 of a Swan-Ganz catheter, 127 patients with a pulmonary-capillary wedge pressure of 18 mm Hg or higher
111 ection fraction (p = 0.02, r = 0.83), higher pulmonary capillary wedge pressure (p = 0.01, r = 0.58)
112 on fraction (p = 0.008, r = 0.88) and higher pulmonary capillary wedge pressure (p = 0.02, r =0.54).
114 hanges in right atrial pressure (P=0.36) and pulmonary capillary wedge pressure (P=0.53) were not.
115 ubgroup, left atrial dilatation, increase of pulmonary capillary wedge pressure, PAP and RAP were mor
116 (2)) was measured by intraarterial catheter, pulmonary capillary wedge pressure (Pcw), continuous car
117 (cardiac index < or =2.5 l/min per m(2) and pulmonary capillary wedge pressure (PCWP) > or =15 mm Hg
118 of right atrial pressure (RAP) >12 mm Hg or pulmonary capillary wedge pressure (PCWP) >15 mm Hg were
119 decreases in creatinine (2.6 to 1.5 mg/dL), pulmonary capillary wedge pressure (PCWP) (32 to 14 mm H
120 d, grouping patients by baseline measures of pulmonary capillary wedge pressure (PCWP) and cardiac in
121 ad as shown by significant increases in both pulmonary capillary wedge pressure (PCWP) and central ve
122 to have a strong positive relationship with pulmonary capillary wedge pressure (PCWP) and left ventr
123 significant relations were observed between pulmonary capillary wedge pressure (PCWP) and sole param
124 s were placed in 11 subjects for measures of pulmonary capillary wedge pressure (PCWP) and SV (thermo
125 Although right atrial pressure (RAP) and pulmonary capillary wedge pressure (PCWP) are correlated
127 ppler echocardiography, BNP measurement, and pulmonary capillary wedge pressure (PCWP) determination.
129 lic velocity (E/Ea) has been correlated with pulmonary capillary wedge pressure (PCWP) in a wide vari
130 es (BNP) can serve as noninvasive markers of pulmonary capillary wedge pressure (PCWP) in the setting
131 t of 60 patients had invasive measurement of pulmonary capillary wedge pressure (PCWP) simultaneous w
134 ardiac index, pulmonary artery pressure, and pulmonary capillary wedge pressure (PCWP) were recorded.
135 ft ventricular ejection fraction, 22 +/- 9%; pulmonary capillary wedge pressure (PCWP), 16 +/- 10 mm
136 of renal sympathetic nerve activity (RSNA), pulmonary capillary wedge pressure (PCWP), and mean arte
137 ation was performed in eight males from whom pulmonary capillary wedge pressure (PCWP), central venou
138 entricular filling pressure, as expressed by pulmonary capillary wedge pressure (PCWP), during lower-
139 D, Corvia Medical) was associated with lower pulmonary capillary wedge pressure (PCWP), fewer symptom
143 endent association between the reductions in pulmonary capillary wedge pressure (PCWP; 25.4, 24.6, 24
144 ween different echocardiographic indices and pulmonary capillary wedge pressures (PCWP) in normal vol
147 orrelated significantly with changes in mean pulmonary capillary wedge pressure (r=0.63, P<0.001).
149 ion fraction exhibited a steeper increase in pulmonary capillary wedge pressure relative to infused v
150 Older women displayed a steeper increase in pulmonary capillary wedge pressure relative to volume in
151 arterial pressures, and it had no effect on pulmonary-capillary wedge pressure, right atrial pressur
152 ncrease in estimated trans-septal gradient (=pulmonary capillary wedge pressure-right atrial pressure
155 re are further rises in pulmonary artery and pulmonary capillary wedge pressures, suggesting abnormal
156 ured included cardiac output, stroke volume, pulmonary capillary wedge pressure, systemic and pulmona
157 on had higher resting pulmonary arterial and pulmonary capillary wedge pressures than the remaining h
159 (6-17) mm Hg, CVP was 8.5 (6-18) mm Hg, and pulmonary capillary wedge pressure was 18 (14-21) mm Hg.
160 x was 1.39 +/- 0.43 L . min(-)(1) . m(-)(2), pulmonary capillary wedge pressure was 31.5 +/- 5.7 mm H
161 )) was 21.6 +/- 4 mL . kg(-)(1) . min(-)(1), pulmonary capillary wedge pressure was 5.9 +/- 4.6 mm Hg
164 heart rate, systemic vascular resistance and pulmonary capillary wedge pressure was evident at 3 min
167 fraction were similar for the two groups but pulmonary capillary wedge pressure was slightly lower fo
168 After study drug administration, exercise pulmonary capillary wedge pressure was substantially imp
169 y artery catheterization with measurement of pulmonary capillary wedge pressure waveform during 5 dif
170 tly by performing a detailed analysis of the pulmonary capillary wedge pressure waveform obtained by
171 ted pulmonary vascular resistance and normal pulmonary capillary wedge pressure, we make a weak recom
172 creased and systemic vascular resistance and pulmonary capillary wedge pressure were decreased, as co
173 e highly correlated (r=0.947), while PVP and pulmonary capillary wedge pressure were found to be mode
174 P), mean pulmonary artery pressure (PAP) and pulmonary capillary wedge pressure were obtained by stan
176 ion, HFpEF subjects displayed an increase in pulmonary capillary wedge pressure with exercise from 20
178 action, augments cardiac output, and reduces pulmonary capillary wedge pressure without causing delet
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。